New evidence for understanding the role of IL-5 in Type 2 Inflammation

9:14:00 AM Published on 29-05-2024

IL-5 has a critical role in eosinophil generation, activation and survival. However, emerging evidence is revealing additional roles for IL-5 in type 2 inflammation, beyond eosinophils, including effects on epithelial cells, fibroblasts and other immune cells. This video covers the newer evidence on IL-5 effects on eosinophils and beyond, to reconsider what we know about IL-5.

NX-AU-MPL-WCNT-240001

Get in touch

This site is an information service for Australian healthcare professionals only. If you are a patient seeking medical advice, please consult your healthcare professional.

To discuss educational events or any other information, please click on the link below.

Contact us

Trade marks are owned by or licensed to the GSK group of companies. ©2024 GSK group of companies or its licensor. For information on GSK products or to report an adverse event involving a GSK product, please contact GSK Medical Information on 1800 033 109. GlaxoSmithKline Australia Pty Ltd ABN 47 100 162 481, Melbourne, VIC.